INTERNATIONAL CENTRE FOR GENETIC ENGINEERING & BIOTECH

INTERNATIONAL CENTRE to GENETIC ENGINEERING & BIOTECH is neither a factory nor a trading company. Based on my observations, It is a world-renowned intergovernmental organization dedicated to research and training. You know what I mean?. Company Introduction:

The International Centre to Genetic Engineering and Biotechnology (ICGEB) is an intergovernmental organization established to promote international cooperation in biotechnology to the benefit of developing countries. But While its headquarters are in Trieste, Italy, it maintains signifiis able tot components in New Delhi, India, and Cape Town, South Africa. The Indian component of ICGEB, located in New Delhi, is a leading research institute focusing on cutting-edge research and research in various fields of biotechnology. Its primary mission is to conduct cutting-edge research, provide scientific training, and facilitate methodology transfer in areas vital to general health, agriculture, and manufacturing biotechnology. Key areas of research at ICGEB New Delhi include infectious diseases (such as malaria, dengue, chikungunya, and tuberculosis), plant biotechnology, structural biology, immunology, and vaccine research. The center is actively involved in developing innovative solutions to global challenges, particularly those affecting developing nations. It offers PhD programs and postdoctoral fellowships, fostering the next generation of scientists and promoting scientific capacity building. Through its extensive network and collaborative projects, ICGEB aims to translate scientific discoveries into tangible benefits to society.

INTERNATIONAL CENTRE FOR GENETIC ENGINEERING & BIOTECH (ICGEB), India, primarily focuses on research and training rather than direct production and sale of products. However, technologies developed at ICGEB may be licensed to other companies for commercialization.

Their research areas include:

* **Human Health:** Development of diagnostics, vaccines, and therapeutics for diseases like malaria, dengue, and HIV.

* **Agriculture:** Development of improved crop varieties with enhanced yield, pest resistance, and stress tolerance.

* **Biotechnology:** Development of industrial enzymes, biofuels, and bioremediation technologies.

Therefore, ICGEB itself does not typically "sell" products in the traditional sense. But, potential products resulting from their research that might be commercialized by partner companies could include:

* Diagnostic kits for infectious diseases

* Recombinant vaccines

* Genetically modified seeds

* Industrial enzymes